FDA approves AI-assisted cancer trial
Resolves: FDA approval for a Medable AI-assisted phase 3 oncology clinical trial confirmed.
user-generated· regulatory
FDA approves AI-assisted cancer trial
Market overview
FDA approves at least one phase 3 oncology trial using Medable's AI agent for monitoring by end of 2027.
regulatory prediction market
- Implied probability (Yes)
- 65%
- Closes
- 2027-12-31
About this prediction
Resolution criteria
FDA approval for a Medable AI-assisted phase 3 oncology clinical trial confirmed.
Source: user-generated
More regulatory markets
- Crypto billionaire Harborne faces FCA scrutiny over £5m gift — 55% Yes
- Crypto billionaire Harborne will face FCA scrutiny — 60% Yes
- Crypto billionaire Christopher Harborne’s donation triggers FCA inquiry into funding transparency — 70% Yes
- Crypto billionaire Christopher Harborne will face parliamentary scrutiny over £5m gift — 55% Yes
- Harborne crypto holdings face regulatory scrutiny — 60% Yes
- SEC approves at least 2 new Bitcoin ETFs by Q4 2027 — 75% Yes
- SEC approves Kalshi's crypto futures products by 2026-Q3 — 55% Yes
- Iran's central bank bans crypto mining by 2027 Q1 — 85% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…